Globus Medical, Inc.
GMED
$91.04
-$0.04-0.04%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.77B | 2.63B | 2.51B | 2.52B | 2.48B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.77B | 2.63B | 2.51B | 2.52B | 2.48B |
| Cost of Revenue | 900.36M | 924.71M | 941.98M | 934.31M | 931.09M |
| Gross Profit | 1.87B | 1.70B | 1.57B | 1.59B | 1.55B |
| SG&A Expenses | 1.11B | 1.04B | 975.35M | 978.10M | 969.43M |
| Depreciation & Amortization | 118.75M | 118.98M | 118.50M | 119.37M | 117.58M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.28B | 2.22B | 2.17B | 2.19B | 2.20B |
| Operating Income | 493.38M | 402.49M | 336.19M | 325.97M | 279.99M |
| Income Before Tax | 460.50M | 373.54M | 232.95M | 120.72M | 121.05M |
| Income Tax Expenses | 36.72M | 16.89M | 47.39M | 17.74M | 29.54M |
| Earnings from Continuing Operations | 423.78 | 356.65 | 185.56 | 102.98 | 91.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 423.78M | 356.65M | 185.56M | 102.98M | 91.51M |
| EBIT | 493.38M | 402.49M | 336.19M | 325.97M | 279.99M |
| EBITDA | 769.63M | 674.68M | 601.50M | 580.54M | 537.49M |
| EPS Basic | 3.13 | 2.63 | 1.36 | 0.76 | 0.67 |
| Normalized Basic EPS | 2.16 | 1.76 | 1.44 | 1.29 | 1.31 |
| EPS Diluted | 3.10 | 2.60 | 1.34 | 0.75 | 0.66 |
| Normalized Diluted EPS | 2.13 | 1.73 | 1.41 | 1.27 | 1.30 |
| Average Basic Shares Outstanding | 543.19M | 544.31M | 544.30M | 542.90M | 544.05M |
| Average Diluted Shares Outstanding | 551.38M | 554.05M | 554.53M | 550.11M | 549.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |